Newsletter Library
June 24, 2025
BIO and Boston: The Global Stage and HLYB
Attending a large conference, medical congress, or trade show can be both…
Newsletter Library
May 27, 2025
Season of Transitions
Three notable transitions worthy of reflection at this point in time.
Newsletter Library
April 22, 2025
Medical Affairs Is Stepping Into the Future
The energy was palpable at the 2025 Medical Affairs Professional Society (MAPS)…
Newsletter Library
The Power of Key Business Questions
October 21, 2024
In our biopharma world, we frequently hear the term “Key Business Questions (KBQs).” And while it’s often thrown around as a buzzword (or buzz…
Decision-Making and Process,Strategy and Planning,All Categories
Newsletter Library
The Underappreciated Value of New Product Planning
September 24, 2024
Decision-Making and Process,Strategy and Planning,All Categories
Newsletter Library
Biopharma Annual Planning Success: Close Your Rings Year-Round
August 21, 2024
How do we think about biopharma annual planning differently? The analogy we will draw on is fitness trackers and apps—built for mindfulness and…
Decision-Making and Process,Strategy and Planning,All Categories
Newsletter Library
The Power of Target Product Profiles: Three Case Studies
July 22, 2024
In the biopharma industry, the Target Product Profile (TPP) is a critical tool for guiding the development and commercialization of new drugs.
Decision-Making and Process,Strategy and Planning,All Categories
Newsletter Library
Unlocking Success: The Power of Target Product Profiles
June 25, 2024
In the ever-evolving biopharma landscape, success hinges not just on innovation but also on a clear roadmap guiding clinical and commercial…
Decision-Making and Process,Strategy and Planning,All Categories
Newsletter Library
Governance: The Glue to a Successful Launch
April 23, 2024
At the core of every successful launch lies a meticulously crafted plan, a robust governance structure, and expert management of its execution.
Decision-Making and Process,Strategy and Planning,All Categories
Newsletter Library
Your Biopharma Data Needs a Strategy
March 26, 2024
In the not-so-distant past, physician prescribing data was essentially a commodity with limited breadth or depth for the purposes of drug development…
Decision-Making and Process,Strategy and Planning,All Categories
Newsletter Library
Juggling Geographic Commercialization Priorities
January 24, 2024
Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country differences, is exponentially…
Decision-Making and Process,Strategy and Planning,All Categories
Newsletter Library
Pipeline Medical Affairs: An Orchestra, Not a Horse Race
October 25, 2023
Every horse race has a starting bell, a push to move as fast as possible, and a finish line. In many ways, the launch of a new drug can feel similar.…
Decision-Making and Process,Strategy and Planning,All Categories
Newsletter Library
Three Big Mistakes
September 26, 2023
Over the past 20 years, The NemetzGroup has been involved in the launch of more than 50 different drugs and has had input into the strategic…
Decision-Making and Process,Strategy and Planning,All Categories